Avalyn Pharma Inc. Common Stock
AVLN | NASDAQ
$25.23
-$0.40 (-1.56%)
Nov 2, 2026, 11:23 AM ET · Market open
TTM Period Ending | TTM 2025 Dec 31, 2025 |
|---|---|
PE Ratio | -14.46 |
PEG Ratio | n/a |
PS Ratio | n/a |
PB Ratio | -5.17 |
P/FCF Ratio | -15.07 |
P/OCF Ratio | -15.13 |
OCF/S Ratio | n/a |
Debt / Equity Ratio | -0.01 |
Quick Ratio | 10.19 |
Current Ratio | 10.19 |
Asset Turnover | n/a |
Interest Coverage | n/a |
Return on Equity | 35.70% |
Return on Assets | -57.23% |
Return on Invested Capital | -67.51% |
Dividend Yield | n/a |
Payout Ratio | n/a |
FCF Payout Ratio | n/a |
Gross Profit Margin | n/a |
Net Profit Margin | n/a |
Pretax Profit Margin | n/a |
Operating Profit Margin | n/a |
FCF Margin | n/a |
EBITDA Margin | n/a |
Add to Watchlist
Select watchlists to add or remove AVLN